{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:23:33Z","timestamp":1791897813092,"version":"4.3.4"},"reference-count":38,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND:<\/jats:title>\n                  <jats:p>Inhaled nitric oxide (iNO) is increasingly prescribed to extremely premature neonates with respiratory distress syndrome (RDS). Most of this off-label use occurs during the first week of life. We studied this practice, hypothesizing that it would not be associated with improved survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>We queried the Pediatrix Medical Group Clinical Data Warehouse to identify all neonates born at 22 to 29 weeks\u2019 gestation from 2004 to 2014. In our study sample, we included singletons who required mechanical ventilation for treatment of RDS and excluded those with anomalies. The primary outcome was death before discharge. Through a sequential risk set approach, each patient who received iNO during the first 7 days of life (\u201ccase patient\u201d) was matched by using propensity scores to a patient who had not received iNO at a chronological age before the case patient\u2019s iNO initiation age (defined as the index age for the matched pair). The association between iNO status and in-hospital mortality was evaluated in a Cox proportional hazards regression model by using age as the time scale with patients entering the risk set at their respective index age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>Among 37\u2009909 neonates in our study sample, we identified 993 (2.6%) who received iNO. The 2 matched cohorts each contained 971 patients. We did not observe a significant association between iNO exposure and mortality (hazard ratio, 1.08; 95% confidence interval, 0.94\u20131.25; P = .29).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Off-label prescription of iNO is not associated with reduced in-hospital mortality among extremely premature neonates with RDS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2017-3108","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T08:30:15Z","timestamp":1518165015000},"source":"Crossref","is-referenced-by-count":33,"title":["Inhaled Nitric Oxide in Extremely Premature Neonates With Respiratory Distress Syndrome"],"prefix":"10.1542","volume":"141","author":[{"given":"William A.","family":"Carey","sequence":"first","affiliation":[{"name":"Divisions of Neonatal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Weaver","sequence":"additional","affiliation":[{"name":"Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin C.","family":"Mara","sequence":"additional","affiliation":[{"name":"Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reese H.","family":"Clark","sequence":"additional","affiliation":[{"name":"Center for Research, Education and Quality, Pediatrix Medical Group, Sunrise, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"issue":"9","key":"2021121018302811700_B1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199702273360901","article-title":"Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.","volume":"336","author":"Neonatal Inhaled Nitric Oxide Study Group","year":"1997","journal-title":"N Engl J Med"},{"issue":"7","key":"2021121018302811700_B2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM200002173420704","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn.","volume":"342","author":"Clark","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121018302811700_B3","first-page":"CD000399","article-title":"Nitric oxide for respiratory failure in infants born at or near term.","author":"Barrington","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2021121018302811700_B4","doi-asserted-by":"crossref","first-page":"F191","DOI":"10.1136\/fn.77.3.F191","article-title":"Changes in oxygenation and pulmonary haemodynamics in preterm infants treated with inhaled nitric oxide.","volume":"77","author":"Subhedar","year":"1997","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9184","key":"2021121018302811700_B5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0140-6736(99)03558-8","article-title":"Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial.","volume":"354","author":"Kinsella","year":"1999","journal-title":"Lancet"},{"key":"2021121018302811700_B6","first-page":"S469","article-title":"Inhaled nitric oxide therapy in premature infants with mild to moderate respiratory distress syndrome.","volume":"85","author":"Srisuparp","year":"2002","journal-title":"J Med Assoc Thai"},{"issue":"22","key":"2021121018302811700_B7","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa031154","article-title":"Inhaled nitric oxide in premature infants with the respiratory distress syndrome.","volume":"349","author":"Schreiber","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"2021121018302811700_B8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1542\/peds.2004-1209","article-title":"Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339).","volume":"115","author":"Field","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"2021121018302811700_B9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa043927","article-title":"Inhaled nitric oxide for premature infants with severe respiratory failure.","volume":"353","author":"Van Meurs","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"2021121018302811700_B10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jpeds.2004.10.019","article-title":"The safety and efficacy of nitric oxide therapy in premature infants.","volume":"146","author":"Hascoet","year":"2005","journal-title":"J Pediatr"},{"issue":"9","key":"2021121018302811700_B11","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1080\/08035250600702594","article-title":"Inhaled nitric oxide in very preterm infants with severe respiratory distress syndrome.","volume":"95","author":"Dani","year":"2006","journal-title":"Acta Paediatr"},{"issue":"4","key":"2021121018302811700_B12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa060442","article-title":"Early inhaled nitric oxide therapy in premature newborns with respiratory failure.","volume":"355","author":"Kinsella","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"2021121018302811700_B13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa061088","article-title":"Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.","volume":"355","author":"Ballard","year":"2006","journal-title":"N Engl J Med"},{"issue":"9738","key":"2021121018302811700_B14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(10)60664-2","article-title":"Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial.","volume":"376","author":"Mercier","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"2021121018302811700_B15","first-page":"CD000509","article-title":"Inhaled nitric oxide for respiratory failure in preterm infants.","author":"Barrington","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2021121018302811700_B16","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-3428","article-title":"Inhaled nitric oxide in preterm infants: a systematic review.","volume":"127","author":"Donohue","year":"2011","journal-title":"Pediatrics"},{"issue":"4","key":"2021121018302811700_B17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1542\/peds.2010-2725","article-title":"Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials.","volume":"128","author":"Askie","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"2021121018302811700_B18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1542\/peds.2010-3507","article-title":"NIH consensus development conference statement: inhaled nitric-oxide therapy for premature infants.","volume":"127","author":"Cole","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"2021121018302811700_B19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1542\/peds.2013-3444","article-title":"Use of inhaled nitric oxide in preterm infants.","volume":"133","author":"Kumar","year":"2014","journal-title":"Pediatrics"},{"issue":"12","key":"2021121018302811700_B20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/jp.2010.37","article-title":"The changing pattern of inhaled nitric oxide use in the neonatal intensive care unit.","volume":"30","author":"Clark","year":"2010","journal-title":"J Perinatol"},{"issue":"4","key":"2021121018302811700_B21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1542\/peds.2014-3290","article-title":"Off-label use of inhaled nitric oxide after release of NIH consensus statement.","volume":"135","author":"Ellsworth","year":"2015","journal-title":"Pediatrics"},{"issue":"8","key":"2021121018302811700_B22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/jp.2016.49","article-title":"Inhaled nitric oxide use in preterm infants in California neonatal intensive care units.","volume":"36","author":"Handley","year":"2016","journal-title":"J Perinatol"},{"issue":"1","key":"2021121018302811700_B23","first-page":"1","article-title":"Births: final data for 2015.","volume":"66","author":"Martin","year":"2017","journal-title":"Natl Vital Stat Rep"},{"issue":"21","key":"2021121018302811700_B24","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society [published correction appears in Circulation. 2016;133(4):e368].","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"key":"2021121018302811700_B25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpeds.2015.11.050","article-title":"Recommendations for the use of inhaled nitric oxide therapy in premature newborns with severe pulmonary hypertension.","volume":"170","author":"Kinsella","year":"2016","journal-title":"J Pediatr"},{"issue":"3","key":"2021121018302811700_B26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jpeds.2012.03.008","article-title":"Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure.","volume":"161","author":"Aikio","year":"2012","journal-title":"J Pediatr"},{"issue":"3","key":"2021121018302811700_B27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jpeds.2012.05.004","article-title":"Inhaled nitric oxide for preterm infants: a Marksman\u2019s approach.","volume":"161","author":"Ball","year":"2012","journal-title":"J Pediatr"},{"issue":"7","key":"2021121018302811700_B28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jamapediatrics.2016.0228","article-title":"Inhaled nitric oxide use in the neonatal intensive care unit: rising costs and the need for a new research paradigm.","volume":"170","author":"Carey","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"19","key":"2021121018302811700_B29","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.","volume":"17","author":"D\u2019Agostino","year":"1998","journal-title":"Stat Med"},{"issue":"25","key":"2021121018302811700_B30","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"2021121018302811700_B31","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"issue":"5","key":"2021121018302811700_B32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jpeds.2014.07.040","article-title":"Pulmonary hypertension in preterm infants: prevalence and association with bronchopulmonary dysplasia.","volume":"165","author":"Mirza","year":"2014","journal-title":"J Pediatr"},{"issue":"1","key":"2021121018302811700_B33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1164\/rccm.201409-1594OC","article-title":"Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.","volume":"191","author":"Mourani","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2021121018302811700_B34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpeds.2007.03.017","article-title":"Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized controlled trial of inhaled nitric oxide.","volume":"151","author":"Hintz","year":"2007","journal-title":"J Pediatr"},{"issue":"2","key":"2021121018302811700_B35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-3476(97)70347-0","article-title":"Nitric oxide inhalation in infants with respiratory distress syndrome.","volume":"130","author":"Skimming","year":"1997","journal-title":"J Pediatr"},{"issue":"5","key":"2021121018302811700_B36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1099-0496(199711)24:5<319::AID-PPUL3>3.0.CO;2-D","article-title":"Response of premature infants with severe respiratory failure to inhaled nitric oxide.","volume":"24","author":"Van Meurs","year":"1997","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"2021121018302811700_B37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-0028-1104743","article-title":"Inhaled nitric oxide for preterm premature rupture of membranes, oligohydramnios, and pulmonary hypoplasia.","volume":"26","author":"Chock","year":"2009","journal-title":"Am J Perinatol"},{"issue":"4","key":"2021121018302811700_B38","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1542\/peds.2015-0144","article-title":"Inhaled nitric oxide for the preterm infant: evidence versus practice.","volume":"135","author":"Finer","year":"2015","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-3108\/922846\/peds_20173108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-3108\/922846\/peds_20173108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T05:26:22Z","timestamp":1639200382000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/141\/3\/e20173108\/37641\/Inhaled-Nitric-Oxide-in-Extremely-Premature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,1]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2017-3108","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,1]]},"article-number":"e20173108"}}